News + Filings Holdings
All 13F 13D/G Other
|
Altium Capital Management LP
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/23/2023 |
SC 13G
| Altium Capital Management LP reports a 5.7% stake in Alimera Sciences, Inc |
04/26/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/21/2022 |
SC 13G
| Altium Capital Management LP reports a 5.2% stake in Astria Therapeutics, Inc. |
11/17/2022 |
SC 13G
| Altium Capital Management LP reports a 7.7% stake in NeuroBo Pharmaceuticals, Inc. |
02/14/2022 |
SC 13G
| Altium Capital Management LP reports a 10% stake in Palisade Bio, Inc. |
02/11/2022 |
SC 13G
| Altium Capital Management LP reports a 5% stake in Renovacor, Inc. |
12/27/2021 |
SC 13G
| Altium Capital Management LP reports a 8.2% stake in Immix Biopharma, Inc. |
12/27/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/17/2021 |
SC 13G
| Altium Capital Management LP reports a 5.7% stake in Creative Medical Technology Holdings, Inc. |
11/12/2021 |
SC 13G
| Altium Capital Management LP reports a 10% stake in Quoin Pharmaceuticals Ltd. |
09/21/2021 |
SC 13G
| Altium Capital Management LP reports a 8.5% stake in Virpax Pharmaceuticals, Inc. |
07/19/2021 |
SC 13G
| Altium Capital Management LP reports a 5.1% stake in INmune Bio, Inc. |
07/12/2021 |
SC 13G
| Altium Capital Management LP reports a 7.5% stake in electroCore, Inc. |
06/07/2021 |
SC 13G
| Altium Capital Management LP reports a 6.7% stake in 1847 Goedeker Inc. |
04/26/2021 |
SC 13G
| Altium Capital Management LP reports a 9.4% stake in Gee Group Inc. |
03/08/2021 |
SC 13G
| Altium Capital Management LP reports a 10% stake in Xtant Medical Holdings, Inc. |
03/08/2021 |
SC 13G
| Altium Capital Management LP reports a 8.9% stake in BriaCell Therapeutics Corp. |
02/24/2021 |
SC 13G
| Altium Capital Management LP reports a 5.9% stake in Hepion Pharmaceuticals, Inc. |
02/22/2021 |
SC 13G
| Altium Capital Management LP reports a 5.4% stake in Phunware, Inc. |
01/29/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/20/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/28/2020 |
SC 13G
| Altium Capital Management LP reports a 7.2% stake in Genprex, Inc. |
12/23/2020 |
SC 13G
| Altium Capital Management LP reports a 6.2% stake in BioCardia, Inc. |
11/16/2020 |
SC 13G
| Altium Capital Management LP reports a 8.3% stake in Ocuphire Pharma, Inc. |
09/21/2020 |
SC 13G
| Altium Capital Management LP reports a 5.3% stake in Muscle Maker, Inc. |
07/20/2020 |
SC 13G
| Altium Capital Management LP reports a 7.2% stake in NanoViricides, Inc. |
07/09/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/08/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
06/10/2020 |
SC 13G
| Altium Capital Management LP reports a 10% stake in ARCA biopharma, Inc. |
06/01/2020 |
SC 13G
| Altium Capital Management LP reports a 5.5% stake in ContraFect Corporation |
05/08/2020 |
SC 13G
| Altium Capital Management LP reports a 9.5% stake in Second Sight Medical Products Inc |
04/10/2020 |
SC 13G
| Altium Capital Management LP reports a 7.2% stake in SG Blocks, Inc. |
04/10/2020 |
SC 13G
| Altium Capital Management LP reports a 5.8% stake in Sonnet Biotherapeutics Holdings, Inc. |
|
|
|